Saturday, July 11, 2026

North Korea’s Table Tennis Team Shocks the World with Olympic Silver

After an eight-year hiatus, North Korea's table tennis team made a striking return to the Olympics, clinching a coveted medal.

Tesla’s Stock Plunge Sparks Lawsuit Against CEO Elon Musk

Tesla shareholders have filed a lawsuit alleging insider trading when CEO Elon Musk sold more than $7.5 billion in stock by the end of 2022.

Why Is South Korea’s Ministry of Unification Quiet on POWs in Ukraine?

South Korea's Ministry of Unification remains silent on North Korean POWs in Ukraine, raising questions about its human rights commitment.

Tag: Truxima

Celltrion’s Truxima becomes first rituximab biosimilar in U.S. to receive interchangeability designation

Celltrion's Truxima gains FDA interchangeability status, enhancing its market position and credibility in blood cancer treatment.

Truxima: How the First Korean Biosimilar Achieved 35.8% Market Share in the U.S.!

Celltrion’s Truxima becomes South Korea's first biosimilar to lead U.S. prescription market, boosted by tariff exemptions and strong growth.

Top News

- Our Sponsors Ad -

Follow us